✓Tender information last checkedLast checked 8 Oct 2026, 17:03.
Opportunity overview
Gamma Irradiation of NHSBT Tissue Allografts and Consumables
NHS Blood and Transplant (NHSBT) is looking to appoint a suitable supplier to provide gamma irradiation services for tissue allografts and consumables used by NHSBT Tissue and Eye Services (TES).
NHSBT wishes to engage with suppliers before commencing a formal procurement process. The purpose of this engagement is to improve NHSBT’s understanding of current market capability, capacity, service delivery options and supplier interest in this requirement.
The successful Supplier will be required to provide gamma irradiation of tissue products to an absorbed dose specification of 25kGy minimum and 40kGy maximum, and consumables to an absorbed dose specification of 25kGy minimum and 45kGy maximum.
The Supplier must be able to process a range of tissue products and consumables, provide suitable frozen storage at approximately -20°C where required, maintain appropriate temperature records and return irradiated products within a maximum turnaround time of 72 hours.
The Supplier must provide an irradiation certificate before products are released back to NHSBT. The certificate must include the minimum and maximum absorbed dose, routine dose, irradiation batch number and the relevant NHSBT product batch number.
The Supplier will also be required to support dose mapping and performance qualification activities, undertake compatibility trials for new materials where required, operate an appropriate quality management system and maintain suitable validation, calibration, recall and business continuity arrangements.
NHSBT intends to hold preliminary market engagement meetings. Meetings are expected to be held remotely, with final dates and times to be confirmed.
To enable NHSBT to finalise the arrangements, interested organisations should send an expression of interest by email to Sahithi Bandi sahithi.bandi@nhsbt.nhs.uk no later than November 13th 2026.The response should include the organization’s name, proposed attendees and a brief overview, or website link, describing the relevant services available.
Participation in this market engagement does not guarantee any future business. NHSBT is not committed to undertaking a procurement exercise or awarding a contract as a result of this notice. NHSBT will not reimburse suppliers for any costs incurred in participating in this engagement.
Classification
CPV85145000 — Services provided by medical laboratories
Lots
Lot 1Value not stated
Documents and notices
Preliminary market engagement notice on Find a TenderOpen source ↗
Published notice details
Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.
Gamma Irradiation of NHSBT Tissue Allografts and Consumables
NHS Blood and Transplant (NHSBT) is looking to appoint a suitable supplier to provide gamma irradiation services for tissue allografts and consumables used by NHSBT Tissue and Eye Services (TES).
NHSBT wishes to engage with suppliers before commencing a formal procurement process. The purpose of this engagement is to improve NHSBT’s understanding of current market capability, capacity, service delivery options and supplier interest in this requirement.
The successful Supplier will be required to provide gamma irradiation of tissue products to an absorbed dose specification of 25kGy minimum and 40kGy maximum, and consumables to an absorbed dose specification of 25kGy minimum and 45kGy maximum.
The Supplier must be able to process a range of tissue products and consumables, provide suitable frozen storage at approximately -20°C where required, maintain appropriate temperature records and return irradiated products within a maximum turnaround time of 72 hours.
The Supplier must provide an irradiation certificate before products are released back to NHSBT. The certificate must include the minimum and maximum absorbed dose, routine dose, irradiation batch number and the relevant NHSBT product batch number.
The Supplier will also be required to support dose mapping and performance qualification activities, undertake compatibility trials for new materials where required, operate an appropriate quality management system and maintain suitable validation, calibration, recall and business continuity arrangements.
NHSBT intends to hold preliminary market engagement meetings. Meetings are expected to be held remotely, with final dates and times to be confirmed.
To enable NHSBT to finalise the arrangements, interested organisations should send an expression of interest by email to Sahithi Bandi sahithi.bandi@nhsbt.nhs.uk no later than November 13th 2026.The response should include the organization’s name, proposed attendees and a brief overview, or website link, describing the relevant services available.
Participation in this market engagement does not guarantee any future business. NHSBT is not committed to undertaking a procurement exercise or awarding a contract as a result of this notice. NHSBT will not reimburse suppliers for any costs incurred in participating in this engagement.
Due
6 Nov 2026, 23:59
Status
scheduled
Documents
Entry 1
Id
095319-2026
Document Type
marketEngagementNotice
Notice Type
UK2
Description
Preliminary market engagement notice on Find a Tender
1 published notice version reviewed by ProcuraAxis.
1 VERSION
1
095319-2026Preliminary market engagement notice on Find a Tender ·
PROCURAAXIS ANALYSIS
ProcuraAxis Analysis
Our approved analysis of the opportunity appears below the official tender information.
ANALYSIS PREVIEW
Opportunity intelligence at a glance
Early-stage market engagement for gamma irradiation of NHSBT tissue allografts and consumables. NHSBT is seeking supplier capability information before deciding whether to run a formal procurement.
Who this may suit
Suitable for providers of validated gamma irradiation services with frozen-storage capability, dose-control and certification processes for medical tissue products and consumables.
Key points identified
Tissue irradiation doseAbsorbed dose of minimum 25 kGy and maximum 40 kGy.Evidence: “tissue products to an absorbed dose specification of 25kGy minimum and 40kGy maximum”
Consumables irradiation doseAbsorbed dose of minimum 25 kGy and maximum 45 kGy.Evidence: “consumables to an absorbed dose specification of 25kGy minimum and 45kGy maximum”
Product handling capabilityProcess a range of tissue products and consumables.Evidence: “The Supplier must be able to process a range of tissue products and consumables”
96% approved-analysis confidence7 supplier criteria identified3 risks or unknowns
ProcuraAxis structures information found in published procurement records, checks the result for consistency and publishes only approved analysis. Confidence describes the completeness and consistency of the available source information; it is not a guarantee of eligibility or contract award.
Early-stage market engagement for gamma irradiation of NHSBT tissue allografts and consumables. NHSBT is seeking supplier capability information before deciding whether to run a formal procurement.
Who this may suit
Suitable for providers of validated gamma irradiation services with frozen-storage capability, dose-control and certification processes for medical tissue products and consumables.
Key deliverables
Gamma irradiation of tissue products at 25–40 kGy absorbed dose
Gamma irradiation of consumables at 25–45 kGy absorbed dose
Frozen storage at approximately -20°C where required
Irradiation certificate containing dose and batch information
Dose mapping, performance qualification and material compatibility-trial support
SUPPLIER REQUIREMENTS
7 criteria identified
Irradiation certificate
99% confidence
Mandatory · 1
View supporting evidence
“The Supplier must provide an irradiation certificate before products are released back to NHSBT.”
Tissue irradiation dose
99% confidence
Absorbed dose of minimum 25 kGy and maximum 40 kGy.
View supporting evidence
“tissue products to an absorbed dose specification of 25kGy minimum and 40kGy maximum”
Consumables irradiation dose
99% confidence
Absorbed dose of minimum 25 kGy and maximum 45 kGy.
View supporting evidence
“consumables to an absorbed dose specification of 25kGy minimum and 45kGy maximum”
Product handling capability
98% confidence
Process a range of tissue products and consumables.
View supporting evidence
“The Supplier must be able to process a range of tissue products and consumables”
Quality and validation arrangements
98% confidence
Appropriate quality management system and suitable validation, calibration, recall and business-continuity arrangements.
View supporting evidence
“operate an appropriate quality management system and maintain suitable validation, calibration, recall and business continuity arrangements”
Qualification support
98% confidence
Support dose mapping and performance qualification; undertake compatibility trials for new materials where required.
View supporting evidence
“required to support dose mapping and performance qualification activities, undertake compatibility trials for new materials where required”
Supplier eligibility
98% confidence
Unknown; this is a preliminary market engagement notice and no formal selection criteria are stated.
View supporting evidence
NHSBT is engaging suppliers before commencing a formal procurement process.
COMMERCIAL AND DELIVERY
Contract intelligence
Commercial
Indicative value
75% confidence
Up to £80,000 GBP; basis and contract value are not stated.
View supporting evidence
Opportunity value maximum is listed as 80000 GBP.
Supplier cost reimbursement
99% confidence
NHSBT will not reimburse costs incurred in participating in market engagement.
View supporting evidence
“NHSBT will not reimburse suppliers for any costs incurred in participating in this engagement.”
Contract terms
99% confidence
Unknown; NHSBT is not committed to undertaking a procurement or awarding a contract.
View supporting evidence
“NHSBT is not committed to undertaking a procurement exercise or awarding a contract as a result of this notice.”
Delivery
Delivery geography
90% confidence
United Kingdom.
View supporting evidence
Delivery location is recorded as UK.
Frozen storage
99% confidence
Provide suitable frozen storage at approximately -20°C where required and maintain appropriate temperature records.
View supporting evidence
“provide suitable frozen storage at approximately -20°C where required, maintain appropriate temperature records”
Turnaround time
99% confidence
Return irradiated products within a maximum of 72 hours.
View supporting evidence
“return irradiated products within a maximum turnaround time of 72 hours”
Release documentation
99% confidence
Provide an irradiation certificate before products are released back to NHSBT, including minimum and maximum absorbed dose, routine dose, irradiation batch number and relevant NHSBT product batch number.
View supporting evidence
“The certificate must include the minimum and maximum absorbed dose, routine dose, irradiation batch number and the relevant NHSBT product batch number.”
PROCEDURE
How to respond
Procurement stage
99% confidence
Planned preliminary market engagement; bidding is not open.
View supporting evidence
“NHSBT wishes to engage with suppliers before commencing a formal procurement process.” Display status: upcoming.
Engagement format
98% confidence
Preliminary market engagement meetings expected to be held remotely; final dates and times are to be confirmed.
View supporting evidence
“Meetings are expected to be held remotely, with final dates and times to be confirmed.”
Expression of interest deadline
99% confidence
13 November 2026.
View supporting evidence
“interested organisations should send an expression of interest by email ... no later than November 13th 2026.”
Expression of interest submission
99% confidence
Email Sahithi Bandi at sahithi.bandi@nhsbt.nhs.uk with organisation name, proposed attendees, and a brief overview or website link describing relevant available services.
View supporting evidence
“The response should include the organization’s name, proposed attendees and a brief overview, or website link, describing the relevant services available.”
Formal procurement route
98% confidence
Unknown.
View supporting evidence
NHSBT is conducting engagement before any formal procurement process.
RISKS AND UNKNOWNS
Points requiring attention
No guaranteed contract opportunity
99% confidence
Participation does not guarantee future business; NHSBT may not run a procurement or award a contract.
View supporting evidence
“Participation in this market engagement does not guarantee any future business.”
Early-stage scope and commercial uncertainty
98% confidence
Final scope, procurement route, timetable, contract terms and formal submission requirements are unknown pending market engagement.
View supporting evidence
NHSBT is seeking market capability information before commencing a formal procurement process.
Operational turnaround requirement
98% confidence
Supplier must be capable of a maximum 72-hour return turnaround, creating a potentially demanding logistics and capacity requirement.
View supporting evidence
“return irradiated products within a maximum turnaround time of 72 hours.”
ProcuraAxis analysis supplements, but does not replace, the original notice and tender documents. Always verify eligibility, deadlines and commercial terms with the issuing authority.
Continue in your ProcuraAxis workspaceFree account · Full approved analysis